Risk Factors Associated With Skin and Soft Tissue Infections Among Hospitalized People Who Inject Drugs
- PMID: 28767536
- PMCID: PMC5659886
- DOI: 10.1097/ADM.0000000000000346
Risk Factors Associated With Skin and Soft Tissue Infections Among Hospitalized People Who Inject Drugs
Abstract
Objectives: Skin and soft tissue infections (SSTIs) are common among people who inject drugs (PWID), and can lead to serious morbidity and costly emergency room and hospital utilization. A range of high-risk injection practices may contribute to these infections. The goal of the current study was to examine risk practices that were associated with SSTIs in a sample of hospitalized PWID.
Methods: PWID (N = 143; 40.6% female) were recruited from inpatient medical units at a large urban hospital and completed a baseline interview that focused on infection risk. Measures included demographics, substances used/injected, and self-report of SSTIs (ie, abscesses, ulcers, or cellulitis) within the past year. The Bacterial Infections Risk Scale for Injectors-a 7-item index-assessed specific behaviors expected to increase the risk of acquiring SSTIs (eg, injection without skin cleaning, intramuscular injection).
Results: The sample was 58% Caucasian and averaged 38.7 (SD = 10.7) years of age. Ninety-three participants (65%) reported at least 1 SSTI within the past year. Using a logistic regression model, the Bacterial Infections Risk Scale for Injectors (odds ratio 1.87, P = 0.004) and total number of injections over the past 3 months (odds ratio 2.21, P = 0.002) were associated with past year SSTIs.
Conclusions: In conclusion, rates of past-year SSTIs were high in this sample of hospitalized PWID. Results suggest that interventions should target specific injection practices to reduce infection risk.
Conflict of interest statement
Conflicts of interest: The authors report no relevant financial conflicts.
Similar articles
-
Behavioral characteristics and injection practices associated with skin and soft tissue infections among people who inject drugs: A community-based observational study.Subst Abus. 2017 Jan-Mar;38(1):105-112. doi: 10.1080/08897077.2016.1263592. Epub 2016 Nov 29. Subst Abus. 2017. PMID: 27897966
-
Self-treatment of skin infections by people who inject drugs.Drug Alcohol Depend. 2020 Jan 1;206:107695. doi: 10.1016/j.drugalcdep.2019.107695. Epub 2019 Oct 28. Drug Alcohol Depend. 2020. PMID: 31786397
-
Association between harm reduction intervention uptake and skin and soft tissue infections among people who inject drugs.Drug Alcohol Depend. 2017 May 1;174:91-97. doi: 10.1016/j.drugalcdep.2017.01.020. Epub 2017 Mar 6. Drug Alcohol Depend. 2017. PMID: 28319754
-
Drawing attention to a neglected injecting-related harm: a systematic review of AA amyloidosis among people who inject drugs.Addiction. 2018 Oct;113(10):1790-1801. doi: 10.1111/add.14257. Epub 2018 Jun 8. Addiction. 2018. PMID: 29697879
-
Community-acquired skin and soft-tissue infections in people who inject drugs.Curr Opin Infect Dis. 2023 Apr 1;36(2):67-73. doi: 10.1097/QCO.0000000000000902. Epub 2023 Jan 25. Curr Opin Infect Dis. 2023. PMID: 36718912 Review.
Cited by
-
«One prick and then it´s done»: a mixed-methods exploratory study on intramuscular injection in heroin-assisted treatment.Harm Reduct J. 2021 Dec 18;18(1):134. doi: 10.1186/s12954-021-00584-3. Harm Reduct J. 2021. PMID: 34922561 Free PMC article.
-
Health programmes and services addressing the prevention and management of infectious diseases in people who inject drugs in Canada: a systematic integrative review.BMJ Open. 2021 Sep 23;11(9):e047511. doi: 10.1136/bmjopen-2020-047511. BMJ Open. 2021. PMID: 34556508 Free PMC article.
-
Severe bacterial infections in people who inject drugs: the role of injection-related tissue damage.Harm Reduct J. 2022 May 2;19(1):41. doi: 10.1186/s12954-022-00624-6. Harm Reduct J. 2022. PMID: 35501854 Free PMC article.
-
Reducing injection intensity is associated with decreased risk for invasive bacterial infection among high-frequency injection drug users.Harm Reduct J. 2019 Jun 17;16(1):38. doi: 10.1186/s12954-019-0312-8. Harm Reduct J. 2019. PMID: 31208419 Free PMC article.
-
Harm Reduction Services to Prevent and Treat Infectious Diseases in People Who Use Drugs.Infect Dis Clin North Am. 2020 Sep;34(3):605-620. doi: 10.1016/j.idc.2020.06.013. Infect Dis Clin North Am. 2020. PMID: 32782104 Free PMC article. Review.
References
-
- Aitken CK, Higgs P. Severe vein damage caused by Temezepam injecting. Aust N Z J Public Health. 2002;26:79. - PubMed
-
- Bassetti S, Battegay M. Staphylococcus aureus infections in injection drug users: Risk factors and prevention strategies. Infection. 2004;32:163–179. - PubMed
-
- Binswanger IA, Kral AH, Bluthenthal RN, et al. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis. 2000;30:579–581. - PubMed
-
- Bradley KA, DeBenedetti AF, Volk RJ, et al. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res. 2007;31:1208–1217. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous